Cargando…
Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients
Background: Although Carbohydrate antigen 19-9 (CA19-9) is considered clinically useful and informative for pancreatic carcinoma (PC), false positive results, and false negative results have restricted its clinical use. Especially missed or delayed diagnosis of PC patients with negative CA19-9 value...
Autores principales: | Zhong, Ailing, Qin, Ruihuan, Qin, Wenjun, Han, Jing, Gu, Yong, Zhou, Lei, Zhang, Hongqin, Ren, Shifang, Lu, Renquan, Guo, Lin, Gu, Jianxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402387/ https://www.ncbi.nlm.nih.gov/pubmed/30873386 http://dx.doi.org/10.3389/fonc.2019.00114 |
Ejemplares similares
-
Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer types
por: Ren, Shifang, et al.
Publicado: (2016) -
Alteration of Serum IgG Galactosylation as a Potential Biomarker for Diagnosis of Neuroblastoma
por: Qin, Wenjun, et al.
Publicado: (2018) -
Relative Quantitation of Subclass-Specific Murine
IgG Fc N-Glycoforms by Multiple Reaction Monitoring
por: Han, Jing, et al.
Publicado: (2020) -
Prediction of neoadjuvant chemotherapeutic efficacy in patients with locally advanced gastric cancer by serum IgG glycomics profiling
por: Qin, Ruihuan, et al.
Publicado: (2020) -
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis
por: Liu, Jing, et al.
Publicado: (2019)